Actavis to buy Allergan for $66 billion
November 17, 2014 at 14:59 PM EST
Irish drugmaker Actavis plc has agreed to buy Botox maker Allergan Inc. in a cash and stock deal worth $66 billion...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|